Asset Details
Do you wish to reserve the book?
Investigating fecal microbial transplant as a novel therapy in dogs with inflammatory bowel disease: A preliminary study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Investigating fecal microbial transplant as a novel therapy in dogs with inflammatory bowel disease: A preliminary study
Do you wish to request the book?
Investigating fecal microbial transplant as a novel therapy in dogs with inflammatory bowel disease: A preliminary study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Investigating fecal microbial transplant as a novel therapy in dogs with inflammatory bowel disease: A preliminary study
2022
Overview
There are limited studies investigating the use of fecal microbial transplant (FMT) in dogs with inflammatory bowel disease (IBD). The aim of this preliminary study was to assess the feasibility of adding FMT to standard therapy (corticosteroids and a hypoallergenic diet) for dogs with IBD and to and to describe the changes in measured outcomes after 30 days of treatment.
Thirteen client-owned dogs with IBD were enrolled in this double blinded, randomized clinical trial. All dogs received corticosteroid therapy and a hypoallergenic diet; dogs were randomized to receive either placebo or FMT. Measured outcomes included the canine chronic enteropathy clinical activity index (CCECAI) at 1 week and 1 month after enrolment. Fecal microbiota were analyzed after extracting DNA from fecal samples and profiling using 16S amplicon sequencing. Dogs in the placebo group not responding to treatment after 1 month were offered FMT.
The CCECAI significantly decreased over time in both groups (p = 0.001). There were no significant differences between the CCECAI of the placebo and FMT group at each time point (F test from ANOVA, p = 0.40). No adverse effects were reported in the 30 days following FMT.
The addition of FMT to standard therapy for IBD was feasible. No significant differences were observed in the CCECAI between groups at each time point. Large scale clinical trials can be performed using these methods to evaluate the longer term effect of FMT on clinical signs, microbial diversity, and other outcomes.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Diet
/ DNA
/ Dogs
/ Ecology and Environmental Sciences
/ Fecal Microbiota Transplantation - methods
/ Feces
/ Inflammatory Bowel Diseases - etiology
/ Inflammatory Bowel Diseases - therapy
/ Inflammatory Bowel Diseases - veterinary
/ Medicine and Health Sciences
/ Microbiota (Symbiotic organisms)
/ Placebos
/ Research and Analysis Methods
/ Therapy
